Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer
Jingjing Qu,Quanhui Mei,Li Liu,Tianli Cheng,Peng Wang,Lijun Chen,Jianying Zhou
Therapeutic Advances in Medical Oncology.2021;13()175883592199296
[DOI]
2Image-guided percutaneous microwave ablation of early-stage non–small cell lung cancer
Yang Ni,Hui Xu,Xin Ye
Asia-Pacific Journal of Clinical Oncology.2020;16(6)320
[DOI]
3Microwave ablation for non-small cell lung cancer with synchronous solitary extracranial metastasis
Yang Ni,Xin Ye,Xia Yang,Guanghui Huang,Wenhong Li,Jiao Wang,Xiaoying Han,Zhigang Wei,Min Meng,Zhigeng Zou
Journal of Cancer Research and Clinical Oncology.2020;146(5)1361
[DOI]
4Attitudes and Practices of Immune Checkpoint Inhibitors in Chinese Patients With Cancer: A National Cross-Sectional Survey
Luping Zhang,Jun Wang,Bicheng Zhang,Qian Chu,Chunxia Su,Hao Wu,Xiaobing Chen,Baocheng Wang,Yongmei Yin,Bo Zhu,Jianguo Sun
Frontiers in Pharmacology.2021;12(5)1361
[DOI]
5The clinical application of camrelizumab on advanced hepatocellular carcinoma
Zhongguang Chen,Xiuhua Lu,Kelly Koral
Expert Review of Gastroenterology & Hepatology.2020;14(11)1017
[DOI]
6

A Partial Response of Pulmonary Pleomorphic Carcinoma to Camrelizumab (PD1 Monoclonal Antibody) Monotherapy: A Case Report

Yi Chen,Hao Zhang,Junfeng Shi,Tongshan Wang
OncoTargets and Therapy.2020;Volume 13(11)12471
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal